SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Denali Therapeutics Q3 EPS $(0.48) Down From $(0.38) YoY, Sales $13.604M Up From $1.195M YoY

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.48) per share. This is a 26.32 percent decrease over losses of $(0.38) per share from the same period last year. The company reported $13.604 million in

Benzinga · -

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.48) per share. This is a 26.32 percent decrease over losses of $(0.38) per share from the same period last year. The company reported $13.604 million in sales this quarter. This is a 1.04K percent increase over sales of $1.195 million the same period last year.